SUMMARY Anaesth. 1993; 70: 94-95) 
Topical anaesthetics are often applied to mucous membranes of the airway before laryngoscopy or bronchoscopy [1] [2] [3] . The plasma concentrations of lignocaine vary after topical administration [1--4] and absorption is affected by the site and method of administration [3, 5] . It has been suggested that the anaesthetic efficacy and plasma concentrations of a topical local anaesthetic may be affected also by the conditions of the mucous membranes [1, 3, 5] .
An anticholinergic agent may be administered before procedures in the mouth and upper airway to inhibit vagal responses and to dry mucous membranes. The present study was designed to evaluate the effect of i.v. glycopyrronium on duration of analgesia and plasma concentrations after topical administration of lignocaine.
METHODS AND RESULTS
After obtaining hospital Ethics Committee approval, we studied 10 healthy, non-smoking volunteers (five females and five males, ages 19-^17 yr, weights 55-100 kg) in a randomized fashion. Each subject served as their own control. At least 24 h elapsed between each experiment.
Subjects were studied in the supine position with a 30° head-up tilt. An antecubital vein was cannulated for i.v. administration of drugs and for obtaining blood samples for measurement of plasma concentrations of lignocaine.
After baseline measurements, eitfier glycopyrronium 4 (ig kg" 1 or normal saline was injected in the same volume over 30 s. Before the experiment, the solutions were prepared in coded syringes by a nurse. The i.v. cannula was flushed with 2 ml of normal saline.
The antisialagogue effect was assessed at 1, 2, 3, 5, 10 and 15 min after administration of the solution using a 0-10 visual analogue scale (VAS): 0 = very dry mouth; 10 = very wet mouth. The time elapsed from drug administration to the point when the subject indicated dryness of the mouth was recorded.
Fifteen minutes after drug administration, the subjects inhaled and held their breath, then lignocaine 100 mg (Xylocain, Astra, Sweden) was sprayed over 10 s on the buccal surfaces and the upper part of the soft palate. Subjects were allowed to swallow, but not to spit. Sensation to pinprick in the soft palate was assessed and scored: 0 = no sensation (anaesthesia); 1 = feeling of touch only (analgesia); 2 = normal sensation (baseline). These tests were performed by the same investigator, who was unaware of the dryness score given by the subject.
During the study the ECG was monitored continuously. Heart rate (HR) and arterial pressures (AP) were recorded every 5 min until lignocaine spray. After the spraying, HR and AP were recorded, analgesia tested and blood obtained at 2, 4, 6, 8, 10, 15, 20, 30 and 40 min. Any symptoms of lignocaine toxicity were noted.
Blood samples for measurement of plasma concentrations of lignocaine were obtained in tubes containing dried lithium heparin. After centrifugation, samples were frozen. Lignocaine concentrations were measured by gas chromatography [6] after completion of the study.
Data were analysed by Wilcoxon signed rank test with P < 0.05 considered statistically significant.
After glycopyrronium, the VAS score indicating the degree of dryness of the mouth decreased gradually from mean 6.7 (range 5-10), to 4.3 (2-6) at 15 min (P < 0.01). Subjects noted increasing dryness of the mouth 7 min (range 2-15 min) after injection. After saline, the score did not change significantly from baseline (6.9 (5-10)) and none of the subjects reported dryness. During the study, nine of 10 subjects receiving glycopyrronium and six of 10 subjects receiving saline scored sensation to pinprick as 0 ( fig. 1 ).
Mean (SD) peak plasma concentration of lignocaine was 0.57 (0.29) ug ml" 1 after glycopyrronium and 0.31 (0.10) ug ml" 1 after saline (P < 0.05). The greatest individual lignocaine concentrations were l^ugml" 1 and 0.48 ug ml" 1 , respectively, reached in 17 min (range 10-40 min) and 29 min (range 8-40 min) (P < 0.05) ( fig. 1 ). Peak lignocaine concentrations and body weight did not correlate (correlation coefficients: 0.11 in both groups). There were no side effects in any subjects after lignocaine.
Mean (SD) HR increased from 70 (14) beat min" 1 at baseline to 78 (16) beat min-1 at 15 min (P < 0.05) and 83 (19) beat min' 1 2 min after lignocaine (P < 0.01) in subjects receiving glycopyrronium. After saline, HR increased in response to lignocaine, from 68 (10) beat min' 1 to 76 (19) beat min" 1 (P < 0.05). At 15 min after drug administration, the difference in HR between groups was significant (P < 0.01). AP did not change significantly in either group.
COMMENT
It has been suggested that anticholinergic drugs, by drying the mouth, increase the degree of topical anaesthesia [5] . In this study, we found that analgesia scores were on average smaller and the duration of analgesia clearly longer after administration of glycopyrronium.
Absorption of lignocaine through the mucous membranes of the airway is rapid and depends not only on the characteristics of the drug, but also on the site of application, being more rapid from the lower than from the upper airway [5] . Efthimou and colleagues showed that only 5 % of variation in the absorption of lignocaine was attributable to sputum volume or cigarette consumption. The most important factor was the dose per unit body weight [3] . We did not find a positive correlation between the maximal concentration of lignocaine and the dose given, but our results indicate that anticholinergic drugs may enhance topically administered lignocaine absorption. This contradicts results of Morrell, Chappell and White [1] . Their study was not, however, focused on the effect of anticholinergics on lignocaine absorption.
The time to reach peak concentrations after topical lignocaine administration has been found to vary [1] [2] [3] [4] . Efthimiou and colleagues sprayed lignocaine on the oral mucosa of unpremedicated volunteers. The dose was larger than ours, but the value of absorption was similar to our control data [3] . Absorption was significantly faster after glycopyrronium in our study. Without anticholinergic pretreatment, topical anaesthetic is diluted and washed by saliva, decreasing contact with the oral mucosa and increasing the amount swallowed. The swallowed lignocaine is probably absorbed slowly in the duodenum, perhaps explaining the slowly increasing and small plasma concentrations.
